Preclinical News and Research

RSS
Allos Therapeutics announces results from phase 2 trial of Pralatrexate in peripheral T-cell lymphoma

Allos Therapeutics announces results from phase 2 trial of Pralatrexate in peripheral T-cell lymphoma

Discovery of groundbreaking technique for body to accept gene therapy

Discovery of groundbreaking technique for body to accept gene therapy

SemBioSys begins phase I/II trial of insulin produced in plant seeds

SemBioSys begins phase I/II trial of insulin produced in plant seeds

Genetic breakdown in Fanconi anemia may have link to HPV-associated cancer

Genetic breakdown in Fanconi anemia may have link to HPV-associated cancer

Researchers develop human embryonic stem cell-based system for modeling ALS

Researchers develop human embryonic stem cell-based system for modeling ALS

New insight into adhesion and migration of dendritic cells could lead to novel cancer treatments

New insight into adhesion and migration of dendritic cells could lead to novel cancer treatments

Genaera starts trial of Trodusquemine in overweight and obese type 2 diabetes

Genaera starts trial of Trodusquemine in overweight and obese type 2 diabetes

Anadys Pharmaceuticals receives fast track for ANA598 treatment of chronic hepatitis C virus

Anadys Pharmaceuticals receives fast track for ANA598 treatment of chronic hepatitis C virus

Eli Lilly withdraws application for additional U.S. indication for Cymbalta for chronic pain

Eli Lilly withdraws application for additional U.S. indication for Cymbalta for chronic pain

MorphoSys and Galapagos enter alliance to co-develop novel therapeutic antibodies in bone and joint disease

MorphoSys and Galapagos enter alliance to co-develop novel therapeutic antibodies in bone and joint disease

Peregrine Pharmaceuticals awarded U.S. patent for anti-viral applications of phospholipid-targeting antibodies

Peregrine Pharmaceuticals awarded U.S. patent for anti-viral applications of phospholipid-targeting antibodies

Immune cells reveal fancy footwork

Immune cells reveal fancy footwork

Scientists develop peptide that converts Bcl-2 protein from a cancer cell's friend to a foe

Scientists develop peptide that converts Bcl-2 protein from a cancer cell's friend to a foe

Novel device enhances efficacy of standard chemotherapy

Novel device enhances efficacy of standard chemotherapy

Medarex starts phase 1b clinical trial with MDX-1106 for the treatment of cancer

Medarex starts phase 1b clinical trial with MDX-1106 for the treatment of cancer

Researchers study effect of ADHD on smoking cessation

Researchers study effect of ADHD on smoking cessation

FDA approves GSK's Promacta (Eltrombopag)

FDA approves GSK's Promacta (Eltrombopag)

KAI Pharmaceuticals reports positive results for KAI-1678 in pain reduction

KAI Pharmaceuticals reports positive results for KAI-1678 in pain reduction

Celator Pharmaceuticals enrols first patient in phase 2 study of CPX-351 in acute myeloid leukemia

Celator Pharmaceuticals enrols first patient in phase 2 study of CPX-351 in acute myeloid leukemia

Early-onset familial Alzheimer disease provides clues to treatment of common Alzheimer's

Early-onset familial Alzheimer disease provides clues to treatment of common Alzheimer's

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.